Cyclacel dismisses auditor Crowe over warrant equity classification issue; engages Bush & Associates

Bio Green Med Solution, Inc.

Audit Committee dismissed Crowe LLP as auditor Nov 5, 2024; Crowe was engaged Aug 19, 2024.
Crowe flagged warrant provisions in April 2024 and prior SPA may preclude equity classification, potentially impacting financial statements.
No disagreements on accounting principles; reportable event not yet discussed with Audit Committee.
New auditor Bush & Associates CPA LLP engaged for FYE Dec 31, 2024, effective immediately.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.